Results 151 to 160 of about 1,820,387 (299)

Macrophage‐to‐Myofibroblast Transdifferentiation Contributes to Pulmonary Fibrosis via the MERTK‐SPP1‐SRC‐TKS5 Signaling Axis

Advanced Science, EarlyView.
MERTK is upregulated in fibrotic macrophages and regulates the expression and activity of SRC and TKS5 through SPP1, mediating transdifferentiation of macrophages‐to‐myofibroblasts (MMT) and promoting pulmonary fibrosis. The figure was created with BioRender.com.
Yungeng Wei, Hua Guo, Xiangsheng Yang, Xiao Xiao Tang   +3 more
wiley   +1 more source

Establishment and effectiveness of a community self-management intervention model for patients with chronic pulmonary heart disease: A prospective observational study. [PDF]

Digit Health
Cheng S, Zhou J, Zhang W, Li X, Qin L, Ding J, Pang S, Zhou J, Song W.   +8 more
europepmc   +1 more source

The incidence of congenital heart disease.

Journal of the American College of Cardiology, 2002
J. Hoffman, S. Kaplan
semanticscholar   +1 more source

ZDHHC17‐Mediated CDK4 Palmitoylation Drives Cell Cycle Progression and Orchestrates Cancer Immune Surveillance

Advanced Science, EarlyView.
ZDHHC17 palmitoylates CDK4, which together with TRAF6‐mediated ubiquitination, drives cell cycle progression and immune surveillance, revealing a rational combination of CDK4 inhibitors with immune checkpoint blockers for ZDHHC17‐driven cancers. ABSTRACT Uncontrolled cell cycle progression is a hallmark of cancer, tightly regulated by both intrinsic ...
Zekang Wang, Peipei Song, Xueji Wu, Lei Wang, Wei Xie, Pinning Feng, Chao Cheng, Jianping Guo   +7 more
wiley   +1 more source

A case of plateau heart disease misdiagnosed as chronic pulmonary heart disease. [PDF]

J Hypertens
Zhang N, Tang F.
europepmc   +1 more source

The pathophysiology of pulmonary hypertension in left heart disease.

American Journal of Physiology - Lung cellular and Molecular Physiology, 2015
Siegfried Breitling, K. Ravindran, N. Goldenberg, W. Kuebler   +3 more
semanticscholar   +1 more source

Mitochondrial Carrier SLC25A13 Drives Ferroptosis Resistance and Immune Evasion via a STAT3–IFI6 Circuit in Breast Cancer

Advanced Science, EarlyView.
SLC25A13 is identified as an immunometabolic driver of triple‐negative breast cancer that sustains ferroptosis resistance and immune evasion through a STAT3–IFI6 circuit. Pharmacologic degradation of SLC25A13 restores ferroptosis sensitivity and enhances anti‐PD‐1 efficacy, highlighting a strategy to convert immune‐cold tumors into immunotherapy ...
Yingze Zhu, Yuhan Tang, Yingcui Chen, Zhuoqi Zhang, Yige Lu, Xinyue Wang, Qiyuan Shi, Wenhui Zhao, Hui Pang   +8 more
wiley   +1 more source

Mechanistic gaps and statistical considerations in pulmonary heart disease: Insights from PAH combination therapy studies. [PDF]

ESC Heart Fail
Zhang Y.
europepmc   +1 more source

Human Urine Stem Cells Alleviate Pulmonary Fibrosis via Inhibiting Macrophage‐Myofibroblast Transition

Advanced Science, EarlyView.
Therapeutic role and mechanism of human urine stem cells (hUSCs) in pulmonary fibrosis. hUSCs alleviated pulmonary fibrosis by selectively inhibiting macrophage‐myofibroblast transition (MMT) in two ways: on one hand, hUSCs inhibited mitochondrial reactive oxygen species (mtROS) production and apoptosis/senescence of epithelial cells in pulmonary ...
Zhou‐Hang Zhang, Guan‐Lin Guo, Xiao‐Hui Guan, Min Hu, Qi‐Ming Huang, Ding‐Wen Guo, Hao‐Cheng Gu, You‐Qiong Zhuo, Ning Li, Hong‐Bo Xin, Ke‐Yu Deng   +10 more
wiley   +1 more source

Significance of serum lncRNA XIST in chronic obstructive pulmonary disease and its progression to pulmonary heart disease. [PDF]

BMC Pulm Med
Huang X, Liang J, Li Y, Wei M, Liu Q, Jiang Y, Wang C, Ding J.   +7 more
europepmc   +1 more source